Exploratory Antinociceptive and Anti-Inflammatory Effects of Dittrichia viscosa Extracts: HPLC-PDA Fingerprinting, Preliminary Acute Tolerability, ADMET Prediction, and Docking-Based Prioritization.

Authors

Sara Tlemcani, Oussama Khibech, Amal Lahkimi, Abdessadek Essadek, Chin-Hung Lai, Anouar Hmamou, Amine Mounadi Idrissi, Maryem Aichouch, Amal Elrherabi, Mohamed Bouhrim, Hicham Bekkari

Published in

Pain research & management. Volume 2026. Issue 1. Pages e7424265.

Abstract

The present exploratory study examined a hydroethanolic extract (HEE) and an ethyl-acetate-derived fraction operationally termed the polyphenolic fraction (PF) of Dittrichia viscosa by combining HPLC-PDA fingerprinting, acute nociception and inflammation models, a 72-h acute oral tolerability screen of HEE, and in silico prioritization. The HPLC-PDA fingerprint of HEE contained 31 peaks. Because the available analytical record did not support validated absolute quantification, platform-exported values are reported only as relative chromatographic abundance. The larger peaks included p-coumaric acid (7.20%), caffeic acid (5.11%), a putative caffeic acid-O-hexoside dimer (4.55%), a putative isorhamnetin-O-hexoside (3.57%), a putative hydroxybenzoic acid hexoside (3.25%), and apigenin (3.23%); six annotations were standard-supported, whereas the remaining assignments were putative. In rats (n = 5/group), every treatment-control comparison in the writhing and formalin models was significant in the summary-statistic Dunnett reanalysis (adjusted p < 0.0001). PF at 100 mg/kg produced 59.5% writhing inhibition and mean differences versus vehicle of -38.46 s (95% CI -40.42 to -36.50) and -23.00 s (95% CI -24.45 to -21.55) in the early and late formalin phases, respectively. In the carrageenan model, significant differences occurred mainly at 6 h; PF at 100 mg/kg differed from vehicle by -0.24 cm (95% CI -0.34 to -0.14; adjusted p = 0.0002). Percentage inhibition values are descriptive. No mortality or overt clinical signs were observed after HEE doses up to 4000 mg/kg during 72 h, which constitutes preliminary acute tolerability evidence for HEE only. Predicted ADMET outputs and AutoDock Vina scores prioritized candidate ligands but do not establish exposure, safety, target inhibition, or causal contribution to the extract-level effects. These exploratory findings support further preclinical investigation, subject to chemical confirmation, raw-data-based longitudinal statistics, direct target assays, and guideline-compliant safety studies.

PMID:
42844975
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.